sertraline (Q407617)

has use

medication

0 references

chemical structure

Sertraline.svg
512 × 334; 5 KB

0 references

stereoisomer of

cis-(-)-sertraline

2 references

(1S,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine

inferred from InChI

1 reference

inferred from InChI

trans-(+/-)-sertraline

1 reference

inferred from InChI

chemical formula

C₁₇H₁₇Cl₂N

1 reference

79617-96-2 (English)

19 November 2016

CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl

1 reference

79617-96-2 (English)

19 November 2016

CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl

1 reference

79617-96-2 (English)

19 November 2016

50 milligram

route of administration

oral administration

1 reference

Anatomical Therapeutic Chemical Classification System

1 reference

14 February 2018

World Health Organisation international non-proprietary name

sertraline (English)

1 reference

sertraline (English)

medical condition treated

19 October 2016

1 reference

obsessive-compulsive disorder

13 December 2016

2 references

13 December 2016

2 October 2018

2 references

13 December 2016

2 October 2018

1 reference

13 December 2016

1 reference

post-traumatic stress disorder

13 December 2016

2 references

13 December 2016

generalized anxiety disorder

2 October 2018

1 reference

2 October 2018

mental disorder

1 reference

2 October 2018

postpartum depression

1 reference

significant drug interaction

2 October 2018

depression

0 references

social anxiety disorder

0 references

isocarboxazid

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

procarbazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(±)-deprenyl

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

zolpidem

1 reference

Zolpidem-Associated Hallucinations and Serotonin Reuptake Inhibition: A Possible Interaction

desmopressin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cangrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

carbamazepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosphenytoin

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

solute carrier family 6 member 4

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

4798

Australian pregnancy category C

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

mass

305.074 dalton

1 reference

selective serotonin reuptake inhibitor

79617-96-2 (English)

19 October 2016

2 references

5 March 2018

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Sertraline

0 references

Identifiers

National Library of Israel J9U ID

987007537058005171

0 references

Library of Congress authority ID

sh93006171

0 references

InChI

InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1

1 reference

79617-96-2 (English)

19 November 2016

2 references

79617-96-2 (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

79617-96-2

2 references

sertraline (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=79617-96-2

9 April 2021

1 reference

Sertraline (English)

19 November 2016

2 references

79617-96-2 (English)

19 November 2016

Reaxys registry number

5753709

1 reference

sertraline (English)

19 October 2016

mapping relation type

2 references

SERTRALINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1

1 reference

SERTRALINE (English)

19 November 2016

2 references

MSBNK-Athens_Univ-AU150001

1 reference

MassBank accession ID

SM862703

0 references

0 references

MSBNK-Athens_Univ-AU150002

0 references

MSBNK-Athens_Univ-AU150003

0 references

MSBNK-Athens_Univ-AU150004

0 references

MSBNK-Waters-WA000289

0 references

MSBNK-Waters-WA000290

0 references

MSBNK-Waters-WA000291

0 references

MSBNK-Waters-WA000292

0 references

MSBNK-Waters-WA000293

0 references

MSBNK-Waters-WA000294

0 references

SPLASH

splash10-056r-0980000000-58873180fd0c95a215b3

0 references

splash10-0bt9-0900000000-35c397f9293e114f3234

0 references

splash10-0a4i-0900000000-569e7b0694b3ef81cf90

0 references

splash10-0a6r-0950000000-2a9cba59b69c41b10a59

0 references

splash10-00b9-2890000000-d53a90b04ec8457ad2f1

0 references

HSDB ID

7037

1 reference

Hazardous Substances Data Bank

28 October 2019

SERTRALINE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

Guide to Pharmacology Ligand ID

Sertraline (English)

publication date

17 November 2015

4798

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

4798

D02.455.426.559.847.638.845.800

sertraline (English)

19 November 2016

Sertraline

0 references

0 references

0 references

0 references

0 references

1 reference

sertraline (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0005010

2 references

2 references

sertraline (English)

19 November 2016

MedlinePlus drug identifier

a697048

0 references

PatientsLikeMe treatment ID

0 references

1 reference

sertraline (English)

19 November 2016

0 references

1 reference

1 reference

sertraline (English)

19 October 2016

1 reference

Microsoft Academic ID (discontinued)

sertraline (English)

19 October 2016

0 references

0 references

1 reference

28 October 2013

1 reference

9 July 2020

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

3GWU (English)

19 October 2016

1 reference

4MMB (English)

19 October 2016

1 reference

imported from Wikimedia project

4MM5 (English)

19 October 2016

1 reference

German Wikipedia

UK Parliament thesaurus ID

507816

subject named as

Sertraline

0 references

UMLS CUI

C0074393

1 reference